Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Yongrong Yao"'
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 4, Pp 2103-2119 (2022)
Checkpoint blockade-based immunotherapy has shown unprecedented effect in cancer treatments, but its clinical implementation has been restricted by the low host antitumor response rate. Recently, chemotherapy is well recognized to activate the immune
Externí odkaz:
https://doaj.org/article/3611c46a77bd4f2f9483ff69748c559b
Publikováno v:
International Journal of Nanomedicine
Yanqing Xu,* Yongrong Yao,* Linxiao Wang, Huachao Chen, Ninghua Tan State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, Peopleâs Republic of China*These
Publikováno v:
Chemical Engineering Journal. 451:138336
Publikováno v:
Science of The Total Environment. 855:158851
Accumulating evidences show that the hazardous substance atmospheric nanoplastics increase the respiratory risk of individuals, but the inside toxicity mechanisms to lung tissue remain unclear. This study aims at investigating the potential mechanism
Publikováno v:
Theranostics. 9:90-103
Activatable theranostic agents, which combine fluorescent reporters with masked chemotherapeutic agents that are activated by tumor-associated stimuli, would be attractive candidates to improve the tumor selectivity of chemotherapy. This work reports
Publikováno v:
Journal of Materials Chemistry B. 6:4351-4359
This work reports a dimeric BODIPY (BDP)-loaded liposome with conjugation of anti-HIF antibodies for dual hypoxia marker imaging and nitroreductase (NTR)-activatable photodynamic therapy (PDT) against hypoxic tumors. In this theranostic nanosystem (d
Publikováno v:
Theranostics. 7:3781-3793
A programmed drug delivery system that can achieve sequential release of multiple therapeutics under different stimulus holds great promise to enhance the treatment efficacy and overcome multi-drug resistance (MDR) in tumor. Herein, multi-organelle-t
Publikováno v:
Biomaterials science. 8(1)
Chemotherapy is a dominant treatment modality for different types and stages of cancer. However, hypoxia is one of the undesirable limitations of chemotherapy, which reduces the therapeutic efficiency in cancer treatment, ultimately leading to failur
Publikováno v:
International Journal of Pharmaceutics. 584:119455
Chronic kidney disease (CKD) is one of the leading public health problems worldwide and finally progresses to end-stage renal disease. The therapeutic options of CKD are very limited. Thus, development of drug delivery systems specific-targeting to k
Publikováno v:
Theranostics. 9(1)
Activatable theranostic agents, which combine fluorescent reporters with masked chemotherapeutic agents that are activated by tumor-associated stimuli, would be attractive candidates to improve the tumor selectivity of chemotherapy. This work reports